Doing it our way now: the approach this company pioneered is becoming the market's way
The model's full reasoning — Q1 2018 call → NOWe need to determine if management describes that their way of doing things is being adopted, copied, or moved toward by others in the market, and that they treat it as validation. Scan the transcript for relevant statements. Management discusses innovations, partnerships, and market trends. They mention that they are making solutions broadly available, that clients are interested in their approach, and that they see RFP activity down. They also talk about their integrated model and how they are pushing boundaries. However, the key is whether others are actually adopting their specific way. They mention that they are pursuing solutions with other payers, and that they have partnerships with PBMs and health plans. They also note that they are seeing an uptick by Optum and Cigna clients of many CVS Pharmacy and MinuteClinic programs. That suggests others are using their programs. But is that "adopting their way"? They also mention that they are making their solutions available to all health plan partners, and that they have proven their model with SilverScript. They say that health plan partners have grown faster because of their services. That indicates others are following their lead. But the question asks specifically: does management describe that the way this company does things is now being adopted, copied, or moved toward by others? Look for explicit statements. For example, Jon Roberts says: "we've been very clear with them that, as we build products – new products, we're going to make them not only available to Aetna, but all of our health plan partners in this open platform." That's about offering to others, not necessarily that others are copying. They also say that clients are looking to reduce vendors and are excited about their innovation. That's more about demand. Management also discusses that they are seeing RFP opportunities less, but that's not about copying. Perhaps the most relevant is when they talk about their approach to chronic disease management and how they are using data and analytics. But they don't say others are copying that. They mention that they are pursuing solutions with other payers for eligibility, but that's about collaboration. I don't see a clear statement that competitors or others are adopting their specific way of doing things. They claim to be innovative and leaders, but they don't describe others following.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| AES | The AES Corporation | Q1 2024 | 2024-05-03 | C+ |
| GGR | Gogoro Inc. | Q1 2023 | 2023-05-11 | D |
| TGT | Target Corporation | Q4 2022 | 2023-02-28 | C |
| ORAN | Orange SA | Q2 2018 | 2018-07-26 | B |
| USFD | US Foods Holding Corp. | Q1 2018 | 2018-05-12 | C |
| SHOO | Steven Madden, Ltd. | Q1 2017 | 2017-04-21 | C |
AES · Q1 2024 → YESThe question is: Does management describe that the WAY THIS COMPANY DOES THINGS is NOW BEING ADOPTED, COPIED, OR MOVED TOWARD BY OTHERS IN ITS MARKET, so that the company's own way of doing things is ...
GGR · Q1 2023 → YESThe question is: Does management describe that the way this company does things is now being adopted, copied, or moved toward by others in its market?
TGT · Q4 2022 → YESThe question is: Does management describe that the way this company does things is now being adopted, copied, or moved toward by others in its market?